bioMérieux S.A. (OTCMKTS:BMXMF) Short Interest Down 19.1% in January

bioMérieux S.A. (OTCMKTS:BMXMF - Get Free Report) saw a significant decline in short interest in January. As of January 15th, there was short interest totalling 118,300 shares, a decline of 19.1% from the December 31st total of 146,200 shares. Based on an average daily volume of 100 shares, the short-interest ratio is presently 1,183.0 days.

bioMérieux Stock Down 1.1 %

OTCMKTS BMXMF traded down $1.35 on Monday, reaching $120.00. 7,190 shares of the stock were exchanged, compared to its average volume of 2,608. The company has a debt-to-equity ratio of 0.10, a current ratio of 2.21 and a quick ratio of 1.20. bioMérieux has a one year low of $93.50 and a one year high of $122.52. The company's 50-day simple moving average is $107.76 and its two-hundred day simple moving average is $110.31.

About bioMérieux

bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.